NDC 0002-7950

Etesevimab

Etesevimab

Etesevimab is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Etesevimab.

Product ID0002-7950_26bc28c0-e8ff-470f-96c7-db44b1e690ab
NDC0002-7950
Product TypeHuman Prescription Drug
Proprietary NameEtesevimab
Generic NameEtesevimab
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-02-09
Marketing CategoryEMERGENCY USE AUTHORIZATION / UNAPPROVED DRUG OTHER
Labeler NameEli Lilly and Company
Substance NameETESEVIMAB
Active Ingredient Strength35 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0002-7950-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7950-01) > 20 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2021-02-09
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.